English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1746]
News [4543]
Articles [210]
Editorials [9]
Conferences [166]
elearning [24]
Acupuncture significantly reduces joint pain for breast cancer patients
Prof Dawn Hershman - Columbia University Medical Center, New York, NY
Acupuncture significantly reduces joint pain for breast cancer patients ( Prof Dawn Hershman - Columbia University Medical Center, New York, NY )
7 Dec 2017
Phase III trial data supports current standard 12-month adjuvant trastuzumab...
Prof Heikki Joensuu - University of Helsinki, Helsinki, Finland
Phase III trial data supports current standard 12-month adjuvant trastuzumab for HER2-positive breast cancer ( Prof Heikki Joensuu - University of Helsinki, Helsinki, Finland )
7 Dec 2017
Temporary ovarian suppression with hormone analogue may preserve fertility...
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
7 Dec 2017
Two years of extended anastrozole therapy as effective as five
Prof Michael Gnant - Medizinischen Universität Wien, Vienna, Austria
Two years of extended anastrozole therapy as effective as five ( Prof Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )
7 Dec 2017
Tandem duplicator phenotypes define 50% of triple negative breast cancers
Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA
Tandem duplicator phenotypes define 50% of triple negative breast cancers ( Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA )
7 Dec 2017
Updated genomic screening tool for life-time breast cancer risk
Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake...
Updated genomic screening tool for life-time breast cancer risk ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )
7 Dec 2017
Temporary ovarian suppression with hormone analogue may preserve fertility...
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
7 Dec 2017
Acupuncture significantly reduces joint pain for breast cancer patients
Prof Dawn Hershman - Columbia University Medical Center, New York, NY
Acupuncture significantly reduces joint pain for breast cancer patients ( Prof Dawn Hershman - Columbia University Medical Center, New York, NY )
7 Dec 2017
Immunotherapy shows early promise for patients with trastuzumab-resistant...
Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Immunotherapy shows early promise for patients with trastuzumab-resistant breast cancer ( Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
7 Dec 2017
HR–positive advanced breast cancer: Ribociclib improved PFS for pre and...
Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA
HR–positive advanced breast cancer: Ribociclib improved PFS for pre and perimenopausal women ( Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA )
7 Dec 2017
HER2low invasive breast cancer: Trastuzumab offers no improvement for invasive...
Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California...
HER2low invasive breast cancer: Trastuzumab offers no improvement for invasive disease free survival ( Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California, USA )
7 Dec 2017
Adjuvant trastuzumab did not improve outcomes for patients with HER2-low breast...
Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California...
Adjuvant trastuzumab did not improve outcomes for patients with HER2-low breast cancer ( Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California, USA )
7 Dec 2017
<1...5253545556...146>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top